Advertisement

Introduction and Background Information

  • Claude Weil

Abstract

Few chemical groups comprise compounds with such diversified actions as the ergot alkaloids and their derivatives, and ergot has been called a treasure house for drugs. The present review is centered on the pharmacology and clinical pharmacology of co-dergocrine mesylate (BAN; ergoloid mesylates, USAN; dihydroergotoxine mesylate, INN; Hydergine®), hereafter referred to as co-dergocrine; information on other ergot alkaloids and derivatives is included only when apposite.

Keywords

Acid Amide Ergot Alkaloid Asymmetric Center Lysergic Acid Uterine Atonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • Claude Weil
    • 1
  1. 1.Pharmaceutical DivisionSANDOZ Ltd.BasleSwitzerland

Personalised recommendations